-
Product Insights
NewNet Present Value Model: Icosavax Inc’s IVXA-12
Empower your strategies with our Net Present Value Model: Icosavax Inc's IVXA-12 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CBX-12 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CBX-12 in Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CBX-12 in Ovarian Cancer Drug Details: CBX-12 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ROSE-12 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ROSE-12 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ROSE-12 in Solid Tumor Drug Details: ROSE12 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DTRMWXHS-12 in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DTRMWXHS-12 in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DTRMWXHS-12 in Follicular Lymphoma Drug Details: DTRMWXHS-12 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CBX-12 in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CBX-12 in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CBX-12 in Metastatic Breast Cancer Drug Details: CBX-12 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – DTRMWXHS-12 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DTRMWXHS-12 in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DTRMWXHS-12 in Mantle Cell Lymphoma Drug Details: DTRMWXHS-12 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (DTRMWXHS-12 + Everolimus + Pomalidomide) in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (DTRMWXHS-12 + Everolimus + Pomalidomide) in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (DTRMWXHS-12 + Everolimus + Pomalidomide) in Follicular Lymphoma...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CBX-12 in Small-Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CBX-12 in Small-Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CBX-12 in Small-Cell Lung Cancer Drug Details: CBX-12 is under development...
-
Product Insights
Litoral Piauiense Solar PV Project 12, Brazil
Litoral Piauiense Solar PV Project 12 is proposed to be built in Piaui, Brazil. The project is at the permitting stage. Empower your strategies with our Litoral Piauiense Solar PV Project 12 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – DTRMWXHS-12 in B-Cell Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DTRMWXHS-12 in B-Cell Non-Hodgkin Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DTRMWXHS-12 in B-Cell Non-Hodgkin Lymphoma Drug Details: DTRMWXHS-12 is under development...